NORTHFIELD, Ill.--(BUSINESS WIRE)--The College of American Pathologists (CAP) and American Society of Clinical Oncology (ASCO) have reaffirmed the Human Epidermal Growth Factor Receptor 2 (HER2) ...
Dr. Antonio Wolff and Dr. Kim Allison discuss the latest ASCO-CAP guideline update on HER2 testing in breast cancer. This guideline update affirms previous recommendations, and provides commentary ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results